• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4608647)   Today's Articles (244)   Subscriber (49376)
For: Moriarty F, Hughes CM. Deprescribing and medicines optimisation, two sides of the same coin? Considerations for design of interventional studies. Basic Clin Pharmacol Toxicol 2023;133:665-668. [PMID: 37183267 DOI: 10.1111/bcpt.13900] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Revised: 04/20/2023] [Accepted: 05/11/2023] [Indexed: 05/16/2023]
Number Cited by Other Article(s)
1
Lundby C, Thompson W. Advancing deprescribing: Learnings from the first international conference on deprescribing. Basic Clin Pharmacol Toxicol 2024;134:3-5. [PMID: 37984365 DOI: 10.1111/bcpt.13963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Accepted: 11/16/2023] [Indexed: 11/22/2023]
2
Spinewine A, Reeve E, Thompson W. Revisiting systematic reviews on deprescribing trials to better inform future practice and research. Br J Clin Pharmacol 2023;89:3758-3764. [PMID: 37522371 DOI: 10.1111/bcp.15864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2023] [Revised: 06/29/2023] [Accepted: 07/01/2023] [Indexed: 08/01/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA